Oxford Immunotec Reports Second Quarter 2020 Financial Results
Second quarter revenue of $5.8 million, a decrease of 70% compared to prior year period, due to the impact of COVID-19 Ended the quarter with approximately $165 million of cash and cash equivalents Third quarter revenue estimated to be between $18 - $19 …